N-Acetyl-L-Leucine, granules for suspension clinical trials

IB1001-304: Effects of N-Acetyl-L-Leucine on CACNA1A Disorders: A Phase III, randomized, placebo-controlled, double-blind, crossover study

This study is testing a new medicine, N-Acetyl-L-Leucine, for people with CACNA1A disorders. It's in the final stages of testing to see if it helps improve movement and coordination problems, using a special rating scale to measure changes.